TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the third quarter 2024 after market close on Monday, October 28, 2024. The TransMedics management team will host a corresponding conference […]
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended to democratize access to single cell analysis. The new offerings – GEM-X Flex and GEM-X Universal Multiplex – introduce significant improvements in performance, workflow and cost effectiveness, enabling more researchers to pursue
Allison Transmission Holdings Inc. (NYSE: ALSN),a leading designer and manufacturer of conventional and electrified vehicle propulsion solutions and the largest global manufacturer of medium- and heavy-duty fully automatic transmissions for commercial and defense vehicles,today announced that it will hold its third quarter 2024 financial results conference call at 5:00 p.m. EDT on Tuesday, October 29,
The Andersons, Inc. (Nasdaq: ANDE) will release its financial results for the third quarter 2024 after 4 p.m. Eastern Time on Monday, November 4, 2024. The company will host a webcast on Tuesday, November 5, 2024, at 11 a.m. Eastern Time to discuss the results and provide a company update. https://mma.prnewswire.com/media/74436/THE_ANDERSONS_LOGO.jpg To listen over the
PARSIPPANY, NJ, Oct. 15, 2024 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that its Series B Preferred Stock investors, Ampersand Capital Partners and 1315 Capital (the “Investors”), have exchanged (the “Exchange”) their existing Series B Preferred Stock for a new issuance of Series C Preferred Stock in order
SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT) (“The Joint or “the Company”), the nation’s largest franchisor of chiropractic care through The Joint Chiropractic(R) network, today announced that it granted equity awards on October 14, 2024 as a material inducement to the employment of the Company’s newly hired President and
VANCOUVER, British Columbia, Oct. 15, 2024 (GLOBE NEWSWIRE) — Prime Mining Corp. (“Prime” or the “Company”) (TSX: PRYM) (OTCQX: PRMNF) (Frankfurt: 04V3) is reporting significant open pit expansion and new underground resources in its 2024 Mineral Resource Estimate (“MRE”) at the Company’s Los Reyes Project (the “Project”), located within the prolific Sierra Madre gold-silver belt
AUSTIN, Texas, Oct. 15, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that it has received approval from the New York State Department of Health’s (NYSDOH) Clinical Laboratory Evaluation Program (CLEP) for OvaWatch(R), the Company’s
DENVER, Oct. 15, 2024 (GLOBE NEWSWIRE) — Ibotta (NYSE: IBTA), a leading technology company providing digital promotions and performance marketing solutions, announced today that it will report third quarter 2024 financial results after the market closes on Wednesday, November 13, 2024. Management will host a conference call and webcast to discuss Ibotta’s financial results, recent
SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2024, after the stock market closes on Tuesday, October 29,